Novel therapies for non-small cell lung cancer

Jessica S. Donington, Chi Wan Koo, Marc S. Ballas

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Lung cancer is the leading cause of cancer-related death in the United States. Emerging technologies for the treatment of early-stage non-small cell lung cancer are currently focused on less invasive approaches to obtaining local tumor control, including minimally invasive and less radical resections, as well as image-guided ablative therapies. Targeted chemotherapeutic agents represent the newest area of treatment for advanced non-small cell lung cancer. These novel agents capitalize on our increased understanding of the diverse biology of the disease. Each of these advanced modalities works best for only a small subset of the population with lung cancer, and efficacious use is highly dependent on appropriate patient selection.

Original languageEnglish (US)
Pages (from-to)175-185
Number of pages11
JournalJournal of Thoracic Imaging
Issue number2
StatePublished - May 1 2011


  • Non-small cell lung cancer
  • bevacizumab
  • epidermal growth factor receptor
  • pemetrexed
  • percutaneous ablative therapy
  • stereotactic body radiation therapy
  • sublobar resection
  • targeted therapies

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Novel therapies for non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this